Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
Formyl peptide receptor-1 (FPR1) is a pattern recognition receptor that is mostly expressed by myeloid cells. In patients with colorectal cancer (CRC), a loss-of-function polymorphism (rs867228) in the gene coding for FPR1 has been associated with reduced responses to chemotherapy or chemoradiothera...
Saved in:
| Main Authors: | Julie Le Naour, Léa Montégut, Yuhong Pan, Sarah Adriana Scuderi, Pierre Cordier, Adrien Joseph, Allan Sauvat, Valerio Iebba, Juliette Paillet, Gladys Ferrere, Ludivine Brechard, Claire Mulot, Grégory Dubourg, Laurence Zitvogel, Jonathan G. Pol, Erika Vacchelli, Pierre-Laurent Puig, Guido Kroemer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2237354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
by: Vincent Carbonnier, et al.
Published: (2023-12-01) -
Immunogenic oncolysis by tigilanol tiglate
by: Jonathan G. Pol, et al.
Published: (2024-12-01) -
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors
by: Cecilia Pesini, et al.
Published: (2024-12-01) -
Tumor cells escape immunosurveillance by hampering LFA-1
by: Shishir Upadhyay, et al.
Published: (2025-01-01) -
Exploring Arsenic Transformation and Chemotaxis in a Pseudomonas sp.
by: Pankaj Kumar Arora, et al.
Published: (2024-12-01)